Dinaciclib Synergizes with BH3 Mimetics Targeting BCL‐2 and BCL‐XL in Multiple Myeloma Cell Lines Partially Dependent on MCL‐1 and in Plasma Cells from Patients
MOLECULAR ONCOLOGY（2023）
Key words
BCL-2 proteins,BH3 mimetics,CDK inhibitors,cell death,multiple myeloma
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined